Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Recommendation of "Buy" from Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) have earned an average recommendation of "Buy" from the ten research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $132.78.

Several research firms recently issued reports on ADUS. JMP Securities reissued a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research report on Thursday, April 10th. Oppenheimer lifted their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Macquarie restated an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. Stephens restated an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th.

Addus HomeCare Price Performance

NASDAQ:ADUS traded down $0.13 on Friday, reaching $99.11. The stock had a trading volume of 6,349 shares, compared to its average volume of 163,381. The firm's fifty day moving average is $100.32 and its two-hundred day moving average is $117.64. The company has a market cap of $1.80 billion, a price-to-earnings ratio of 22.74, a P/E/G ratio of 1.41 and a beta of 0.93. Addus HomeCare has a 12-month low of $87.88 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, research analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of the business. Quarry LP acquired a new position in Addus HomeCare during the 3rd quarter valued at approximately $28,000. Natixis increased its stake in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after purchasing an additional 132 shares during the period. Smartleaf Asset Management LLC raised its stake in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares in the last quarter. Parkside Financial Bank & Trust increased its holdings in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after purchasing an additional 148 shares during the period. Finally, Meeder Asset Management Inc. bought a new stake in shares of Addus HomeCare during the fourth quarter valued at about $77,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.